Volume 22 (2023)
Volume 21 (2022)
Volume 20 (2021)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
Alternate dosing of fingolimod in relapsing-remitting multiple sclerosis: A systematic review

Fereshteh Ghadiri; Omid Mirmosayyeb; Mohammad Ali Sahraian; Abdorreza Naser Moghadasi; Mahsa Ghajarzadeh

Articles in Press, Accepted Manuscript, Available Online from 13 March 2023

  Background: Fingolimod is approved in relapsing-remitting multiple sclerosis (RRMS) with the recommended dose of 0.5 mg daily. To tackle possible adverse events, some clinicians may reduce the dose of fingolimod, mainly in the alternate-day form. We systematically reviewed the literature for efficacy ...  Read More

Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?

Omid Mirmosayyeb; Mahdi Barzegar; Nasim Nehzat; Soroush Najdaghi; Behnaz Ansari; Vahid Shaygannejad

Volume 19, Issue 2 , April 2020, , Pages 59-66


  Background: Multiple sclerosis (MS) is a common autoimmune inflammatory disease in the central nervous system (CNS) without exact pathology. Environmental factors such as infections have a causal or protective role in MS. Helicobacter pylori (HP) is one of the infections in digestive diseases and previous ...  Read More

Serum leptin levels in Iranian patients with Parkinson's disease

Mehri Salari; Mahdi Barzegar; Masoud Etemadifar; Omid Mirmosayyeb

Volume 17, Issue 2 , April 2018, , Pages 71-77

  Background: Parkinson's disease (PD), the second most prevalent neurodegenerative disorder, has been related with weight loss and energy balance. Some studies showed that leptin might be playing an important role in satiety, energy balance and immune response. The aim of this study was to evaluate serum ...  Read More

Demographic features and clinical characteristics of patients with Parkinson’s disease in Isfahan, Iran

Mehri Salari; Omid Mirmosayyeb; Masoud Etemadifar; Vahid Shaygannejad; Fariborz Khorvash; Mohammad Reza Najafi; Fereshteh Ashtari; Ahmad Chitsaz

Volume 17, Issue 1 , January 2018, , Pages 6-10

  Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder. Its worldwide incidence rate varies between 18 and 418 cases per 100000 annually. This cross-sectional study was carried out with the aim to identify the clinical characteristics and demographic features of a ...  Read More

Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson’s disease, Isfahan, Iran

Mehri Salari; Ahmad Chitsaz; Masoud Etemadifar; Mohammad Reza Najafi; Omid Mirmosayyeb; Maryam Bemanalizadeh; Fatemeh Panahi; Hosna Mirzajani

Volume 16, Issue 3 , July 2017, , Pages 118-124

  Background: Parkinson’s disease (PD) is diagnosed on the basis of motor symptoms, but non-motor symptoms (NMS) have high prevalence in PD and often antecede motor symptoms for years and cause severe disability. This study was conducted to determine the prevalence of NMS in patients with PD.Methods: ...  Read More